Nitric oxide induces SOCS-1 expression in human monocytes in a TNF-α-dependent manner

Journal of Endotoxin Research

Volumn 12, Issue 5, 2006, Pages 296-306

  González León, M Carmen ^a   Soares Schanoski, Alessandra ^a   del Fresno, Carlos ^a   Cimadevila, Agata ^a   Goméz Piña, Vanesa ^a   Mendoza Barberá, Elena ^a   García, Felipe ^b   Marín, Elvira ^c   Arnalich, Francisco ^d   Fuentes Prior, Pablo ^e   López Collazo, Eduardo ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Discover Unit   (Spain)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e Institut Català de Ciències Cardiovasculars   (Spain)

Author keywords

Inflammation; Monocyte; Nitric oxide; SOCS 1; TNF

Indexed keywords

ENDOTOXIN ANTIBODY; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; S NITROSOGLUTATHIONE; SUPPRESSOR OF CYTOKINE SIGNALING 1; TUMOR NECROSIS FACTOR ALPHA; SOCS1 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ARTICLE; CELL VIABILITY; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; PROTEIN EXPRESSION; PROTEIN ISOLATION; CELL CULTURE; DRUG EFFECT; GENETICS; KINETICS; METABOLISM;

CELLS, CULTURED; HUMANS; KINETICS; MONOCYTES; NITRIC OXIDE; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548437576     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/09680519060120050501     Document Type: Article

References (60)

1. Moncada S. Nitric oxide: Discovery and impact on clinical medicine. J R Soc Med 1999; 92: 164-169.
2. Chen T., Zamora R., Zuckerbraun B., Billiar TR Role of nitric oxide in liver injury. Curr Mol Med 2003; 3: 519-526.
3. Brennan PA, Moncada S. From pollutant gas to biological messenger: The diverse actions of nitric oxide in cancer. Annu Rev Coll Surg 2002; 84: 75-78.
4. Zeidler MR, Kleerup EC, Tashkin DP Exhaled nitric oxide in the assessment of asthma. Curr Opin Pulmon Med 2004; 10: 31-36.
5. Guzik TJ, Korbut R., Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003; 54: 469-487.
6. Boje KM Nitric oxide neurotoxicity in neurodegenerative diseases. Front Biosci 2004; 9: 763-776.
7. Zucker IH, Schultz HD, Li YF, Wang Y., Wang W., Patel KP The origin of sympathetic outflow in heart failure: The roles of angiotensin II and nitric oxide. Prog Biophys Mol Biol 2004; 84: 217-232.
8. Okuno T., Nakatsuji Y., Kumanogoh A. et al. Loss of dopaminergic neurons by the induction of inducible nitric oxide synthase and cyclooxygenase-2 via CD40: Relevance to Parkinson's disease. J Neurosci Res 2005; 86: 874-872.
9. James S. Role of nitric oxide in parasitic infections. Microb. Ref. 1995; 59: 533-547
10. Nathan C., Xie Q. Nitric oxide synthases: Roles, tolls and controls. Cell 1994; 78: 915-918.
11. Scharton-Kersten TM, Yap G., Magram J., Sher A. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J Exp Med 1997; 185: 1261-1273.
12. Giacomodonato MN, Goren NB, Sordelli DO et al. Involvement of intestinal inducible nitric oxide synthase (iNOS) in the early stages of murine salmonellosis. FEMS Microbiol Lett 2003; 223: 231-238.
13. Cantoni L., Di Nicolantonio F., Barelli D., Rizzardini M., De Matteis F. Modulation of cerebellar and hepatic nitric oxide synthase by exogenous arginine and endotoxin. Nitric Oxide 2001; 5: 198-207.
14. Suschek CV, Schnorr O., Kolb-Bachofen V. The role of iNOS in chronic inflammatory processes in vivo: Is it damage-promoting, protective, or active at all? Curr Mol Med 2004; 4: 763-775.
15. Salzman AL, Eaves-Pyles T., Linn SC, Denenberg AG, Szabo C. Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology 1998; 114: 93-102.
16. Salzman A., Denenberg AG, Ueta I., O'Connor M., Linn SC, Szabo C. Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. Am J Physiol 1996; 270: 565-573.
17. Witthoft T., Eckmann L., Kim JM, Kagnoff MF Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells. Am J Physiol 1998; 275: 564-571.
18. Gomez-Guerrero C., Lopez-Franco O., Suzuki Y. et al. Nitric oxide production in renal cells by immune complexes: Role of kinases and nuclear factor-kappaB. Kidney Int 2002; 62: 2022-2034.
19. Nicolson AG, Haites NE, McKay NG, Wilson HM, MacLeod AM, Benjamin N. Induction of nitric oxide synthase in human mesangial cells. Biochem Biophys Res Commun 1993; 193: 1269-1274.
20. Hirabayashi N., Tanimura H., Yamaue H. Nitrite/nitrate oxide and cytokines changes in patients with surgical stress. Dig Dis Sci 2005; 50: 893-897.
21. Iskit AB, Guc O. Effects of endothelin and nitric oxide on organ injury, mesenteric ischemia, and survival in experimental models of septic shock. Acta Pharmacol Sin 2003; 24: 953-957.
22. Strand OA, Leone A., Giercksky KE, Kirkeboen KA Nitric oxide indices in human septic shock. Crit Care Med 2000; 28: 2779-2785.
23. Groeneveld AB, Hartemink KJ, de Groot MC, Visser J., Thijs LG Circulating endothelin and nitrate-nitrite relate to hemodynamic and metabolic variables in human septic shock. Shock 1999; 11: 160-166.
24. Kim JM, Kim JS, Jung HC, Song IS, Kim CY Up-regulation of inducible nitric oxide synthase and nitric oxide in Helicobacter pylori-infected human gastric epithelial cells: Possible role of interferon-gamma in polarized nitric oxide secretion. Helicobacter 2002; 7: 116-128.
25. Pastor CM, Suter PM Evidence that humans produce less nitric oxide than experimental animals in septic shock. Crit Care Med 1998; 26: 1135-1142.
26. Albina JE On the expression of nitric oxide synthase by human macrophages. Why no NO?. J Leukoc Biol 1995; 58: 643-649.
27. Busse R., Mulsch A. Induction of nitric oxide by cytokines in vascular smooth muscle cells. FEBS Lett 1990; 275: 87-90.
28. Llorens S., Jordan J., Nava E. The nitric oxide pathway in the cardiovascular system. J Physiol Biochem 2002; 58: 179-188.
29. Harrison DG, Cai H. Endothelial control of vasomotion and nitric oxide production. Cardiol Clin 2003; 21: 289-302.
30. Grip O., Janciauskiene S., Lindgren S. Macrophages in inflammatory bowel disease. Curr Drug Targets Inflamm Allergy 2003; 2: 155-160.
31. Linton MF, Fazio S. Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord 2003; 27: 35-40.
32. Barthlen W., Stadler J., Lehn NL, Miethke T., Bartels H., Siewert JR Serum levels of end products of nitric oxide synthesis correlate positively with tumor necrosis factor alpha and negatively with body temperature in patients with postoperative abdominal sepsis. Shock 1994; 2: 398-401.
33. Xiong H., Zhu C., Li F. et al. Inhibition of interleukin-12 p40 transcription and NF-kappa B activation by nitric oxide in murine macrophages and dendritic cells. J Biol Chem 2003;279: 10776-10783.
34. del Fresno C., Gomez-Garcia L., Caveda L. et al. Nitric oxide activates the expression of IRAK-M via the release of TNF-alpha in human monocytes. Nitric Oxide 2004; 10: 213-220.
35. D'Acquisto F., Maiuri MC, de Cristofaro F., Carnuccio R. Nitric oxide prevents inducible cyclooxygenase expression by inhibiting nuclear factor-kappa B and nuclear factor-interleukin-6 activation. Naunyn Schmiedebergs Arch Pharmacol 2001; 364: 157-165.
36. Brune B., Golkel C., von Knethen A. Cytokine and low-level nitric oxide prestimulation block p53 accumulation and apoptosis of RAW 264.7 macrophages. Biochem Biophys Res Commun 1996; 229: 396-401.
37. von Knethen A., Callsen D., Brune B. NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol Biol Cell 1999; 10: 361-372.
38. Janssens S., Beyaert R. Functional diversity and regulation of different interleukin- 1 receptor-associated kinase (IRAK) family members. Mol Cell 2003; 11: 293-302.
39. Escoll P., del Fresno C., Garcia L. et al. Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem Biophys Res Commun 2003;311: 465-472.
40. Kobayashi K., Hernandez LD, Galan JE, Janeway CA, Medzhitov R., Flavell RA IRAKM is a negative regulator of Toll-like receptor signaling. Cell 2002; 110: 191-202.
41. del Fresno C., Otero K., Gomez-Garcia L. et al. Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4. J Immunol 2005; 174: 3032-3040.
42. Starr R., Willson TA, Viney EM et al. A family of cytokine-inducible inhibitors of signalling. Nature 1997; 387: 917-921.
43. Nicola NA, Greenhalgh CJ The suppressors of cytokine signaling (SOCS) proteins: Important feedback inhibitors of cytokine action. Exp Hematol 2000; 28: 1105-1112.
44. Naka T., Tsutsui H., Fujimoto M. et al. SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo. Immunity 2001; 14: 535-545.
45. Baetz A., Frey M., Heeg K., Dalpke AH Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells. J Biol Chem 2004; 279: 54708-54715.
46. Kimura A., Naka T., Muta T. et al. Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STAT. Proc Natl Acad Sci USA 2005; 102: 17089-17094.
47. Kinjyo I., Hanada T., Inagaki-Ohara K. et al. SOCS 1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 2002; 17: 583-591.
48. Nakagawa R., Naka T., Tsutsui H. et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 2002; 17: 677-687.
49. Eigler A., Sinha B., Endres S. Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells. Biochem Biophys Res Commun 1993; 196: 494-501.
50. Kuo HP, Wang CH, Huang KS et al. Nitric oxide modulates interleukin-1beta and tumor necrosis factor-alpha synthesis by alveolar macrophages in pulmonary tuberculosis. Am J Respir Crit Care Med 2000; 161: 192-199.
51. Matata BM, Galinanes M. Peroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor-kappaB DNA binding activity. J Biol Chem 2002; 277: 2330-2335.
52. Deakin AM, Payne AN, Whittle BJR, Moncada S. The modulation of IL-6 and TNF-release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma. Cytokine 1995; 7: 408-416.
53. Ignaro LJ, Napoli C., Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide, (an overview). Circ Res 2002; 90:21-28.
54. Napoli C., Ignarro LJ Nitric oxide and artherosclerosis. Nitric Oxide 2001; 5: 88-97.
55. Kojda G., Harrison D. Interaction between NO and reactive oxygen species: Pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 1999; 43: 562-571.
56. López-Collazo E., Hortelano S., Boscé L. Interferon-alpha/ beta inhibits the apoptosis induced by lipopolysaccharide and interferon-gamma in murine peritoneal macrophages. J Interferon Cytokines Res 1998; 18: 461-467.
57. Boscé L., Hortelano S. Mechanism of nitric oxide-dependent apoptosis: Involvement of mitochondrial mediators. Cell Signal 1999; 11: 239-244.
58. Taylor EL, Megson IL, Haslett C., Rossi AG Nitric oxide: A key regulator of myeloid inflammatory cell apoptosis. Cell Death Differ 2003; 10: 418-430.
59. Albina JE, Reichner JS Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasis Rev 1998; 17: 39-53.
60. Schindler H., Bogdan C. NO as a signaling molecule: Effects on kinases. Int Immunopharm 2001; 1: 1443-1455.